These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thyroid hormone and the cardiovascular system. Danzi S; Klein I Med Clin North Am; 2012 Mar; 96(2):257-68. PubMed ID: 22443974 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and metabolic issues in patients with thyroid dysfunction will be highlighted at the Fifth Anniversary of ATA Spring Meetings in March 2008. Larsen PR; Baxter JD Thyroid; 2008 Feb; 18(2):101. PubMed ID: 18279010 [No Abstract] [Full Text] [Related]
8. The crosstalk between thyroid hormones and the Renin-Angiotensin System. Barreto-Chaves ML; Carrillo-Sepúlveda MA; Carneiro-Ramos MS; Gomes DA; Diniz GP Vascul Pharmacol; 2010; 52(3-4):166-70. PubMed ID: 19857605 [TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone and atherosclerosis. Ichiki T Vascul Pharmacol; 2010; 52(3-4):151-6. PubMed ID: 19808101 [TBL] [Abstract][Full Text] [Related]
10. Thyroid Disease and the Heart. Klein I; Danzi S Curr Probl Cardiol; 2016 Feb; 41(2):65-92. PubMed ID: 26792255 [TBL] [Abstract][Full Text] [Related]
11. [Thyroid hormone and the cardiovascular system]. Takasu N Nihon Rinsho; 2006 Dec; 64(12):2330-8. PubMed ID: 17154101 [TBL] [Abstract][Full Text] [Related]
12. Dr Giacomo Rossitto interviews Professor Rhian Touyz, on the translational applications of vascular smooth muscle cell biology in cardiovascular disease. Rossitto G; Touyz R Cardiovasc Res; 2018 May; 114(6):e43. PubMed ID: 29897497 [No Abstract] [Full Text] [Related]
13. [Thyroid hormone and the cardiovascular system]. Fraczek MM; Łacka K Pol Merkur Lekarski; 2014 Sep; 37(219):170-4. PubMed ID: 25345279 [TBL] [Abstract][Full Text] [Related]
14. Effects of thyroid hormones on the heart. Vargas-Uricoechea H; Bonelo-Perdomo A; Sierra-Torres CH Clin Investig Arterioscler; 2014; 26(6):296-309. PubMed ID: 25438971 [TBL] [Abstract][Full Text] [Related]
15. [Thyroid hormones and the cardiomyocytes]. Gatnar A; Marek B; Pakuła D; Kajdaniuk D; Kos-Kudła B; Borgiel-Marek H; Gnot R; Pakuła P; Pawłowska M Endokrynol Pol; 2006; 57(2):144-8. PubMed ID: 16773590 [TBL] [Abstract][Full Text] [Related]
16. Subclinical Hyperthyroidism and the Cardiovascular Disease. Delitala AP Horm Metab Res; 2017 Oct; 49(10):723-731. PubMed ID: 28915531 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism: pathophysiology and management. Duggal J; Singh S; Barsano CP; Arora R J Cardiometab Syndr; 2007; 2(3):198-206. PubMed ID: 17786084 [TBL] [Abstract][Full Text] [Related]
19. Thyroid disease and the cardiovascular system. Danzi S; Klein I Endocrinol Metab Clin North Am; 2014 Jun; 43(2):517-28. PubMed ID: 24891175 [TBL] [Abstract][Full Text] [Related]
20. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation. Diniz GP; Takano AP; Barreto-Chaves ML Mol Cell Endocrinol; 2013 Jul; 374(1-2):117-24. PubMed ID: 23623871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]